GSE6532 and GSE9195 datasets: sub-set of 15 endocrine- resistant tumours profiled using U133-Plus2 chips

TamU133 Plus 2 picture

Red: the pathway is active, blue: the pathway is inactive, grey: the classification is inconclusive

Endocrine resistance is defined as relapse within 3 years of adjuvant treatment

HG-U133 Plus-2 data selected from datasets GSE6532 and GSE9195